Virtus ETF Advisers’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Virtus ETF Advisers’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,347	Closed	-$91.2K	–	458
2023 Q1	$91.2K	Sell	26,347 -10,129	-28%	-$49.1K	0.05%	359
2022 Q4	$152K	Buy	36,476 +24,945	+216%	+$94.4K	0.08%	341
2022 Q3	$46K	Buy	11,531 +85	+0.7%	+$645	0.02%	435
2022 Q2	$129K	Buy	11,446 +8,310	+265%	+$99.6K	0.05%	354
2022 Q1	$51K	Sell	3,136 -189	-6%	-$4.84K	0.02%	364
2021 Q4	$158K	Buy	3,325 +400	+14%	+$24K	0.06%	329
2021 Q3	$212K	Sell	2,925 -161	-5%	-$11.6K	0.09%	258
2021 Q2	$259K	Sell	3,086 -4,774	-61%	-$315K	0.11%	206
2021 Q1	$381K	Buy	7,860 +135	+2%	+$7.32K	0.16%	191
2020 Q4	$364K	Buy	+7,725	New	+$304K	0.15%	165

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus ETF Advisers's NBP Position: Q2 2023 in Review

Virtus ETF Advisers sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 26,347 shares — an estimated $91.2K sold.

Virtus ETF Advisers first reported a position in NBP in Q4 2020 and held it in 10 quarters. The position peaked at $381K in Q1 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

Virtus ETF Advisers reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Virtus ETF Advisers sold 26,347 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $91.2K.
Virtus ETF Advisers first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 10 quarters.
Virtus ETF Advisers's NovaBridge Biosciences American Depositary Shares position peaked at $381K in Q1 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.